Insight Molecular Diagnostics Ownership | Who Owns Insight Molecular Diagnostics?


OverviewForecastRevenueFinancialsChartTranscripts

Insight Molecular Diagnostics Ownership Summary


Insight Molecular Diagnostics is owned by 7.16% institutional investors, 20.02% insiders, and 72.83% retail investors. Broadwood capital is the largest institutional shareholder, holding 39.15% of IMDX shares.

IMDX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInsight Molecular Diagnostics7.16%20.02%72.83%
SectorHealthcare Stocks 35.34%11.88%52.77%
IndustryDiagnostics & Research Stocks50.92%10.77%38.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Broadwood capital11.93M39.15%$39.14M
Awm investment company2.81M9.21%$9.20M
Pura vida investments947.13K3.11%$3.11M
Alyeska investment group840.78K2.76%$2.76M
Heights capital management392.55K1.29%$1.29M
Geode capital management262.05K0.86%$860.17K
Fny investment advisers247.42K0.81%$811.00K
Blackrock funding, inc. /de135.34K0.44%$443.93K
Vanguard fiduciary trust132.59K0.44%$434.90K
Family office research127.27K0.42%$417.43K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pura vida investments947.13K20.88%$3.11M
Broadwood capital11.93M2.76%$39.14M
Awm investment company2.81M1.02%$9.20M
Heights capital management392.55K0.36%$1.29M
Fny investment advisers247.42K0.35%$811.00K
Family office research127.27K0.18%$417.43K
Alyeska investment group840.78K0.01%$2.76M
Ghisallo capital management70.69K0.01%$231.88K
683 capital management29.00K0.01%$95.12K
Xtx topco30.35K0.00%$99.56K

Top Buyers

HolderShares% AssetsChange
Alyeska investment group840.78K0.01%840.78K
Broadwood capital11.93M2.76%521.74K
Heights capital management392.55K0.36%392.55K
Fny investment advisers247.42K0.35%206.84K
Vanguard fiduciary trust132.59K0.00%132.59K

Top Sellers

HolderShares% AssetsChange
683 capital management29.00K0.01%-48.20K
Jane street group---42.47K
Susquehanna group, llp56.09K--16.36K
Omers administration10.50K0.00%-15.66K
Citadel advisors---15.65K

New Positions

HolderShares% AssetsChangeValue
Alyeska investment group840.78K0.01%840.78K$2.76M
Heights capital management392.55K0.36%392.55K$1.29M
Vanguard fiduciary trust132.59K0.00%132.59K$434.90K
Family office research127.27K0.18%127.27K$417.43K
Ghisallo capital management70.69K0.01%70.69K$231.88K

Sold Out

HolderChange
Tower research capital llc (trc)-250.00
Hudson bay capital management lp-13.06K
Renaissance-13.40K
Citadel advisors-15.65K
Jane street group-42.47K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202620-41.18%2,180,616-86.90%70.26%14-12.50%--100.00%
Dec 31, 20253425.93%16,651,6002.26%512.01%1677.78%7-
Sep 30, 202527-10.00%16,282,8846.65%502.24%9-43.75%716.67%
Jun 30, 2025303.45%15,267,294-4.86%471.22%16-5.88%620.00%
Mar 31, 20252916.00%16,047,85891.76%622.69%1713.33%5-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 24, 2026BROADWOOD PARTNERS, L.P.-Buy$137.08K
Apr 24, 2026BROADWOOD PARTNERS, L.P.-Buy-
Apr 27, 2026BROADWOOD PARTNERS, L.P.-Buy$913.13K
Apr 27, 2026BROADWOOD PARTNERS, L.P.-Buy-
Apr 23, 2026BROADWOOD PARTNERS, L.P.-Buy$982.03K

Insider Transactions Trends


DateBuySell
2026 Q212-
2026 Q12-
2025 Q4--
2025 Q3--
2025 Q113-

IMDX Ownership FAQ


Who Owns Insight Molecular Diagnostics?

Insight Molecular Diagnostics shareholders are primarily institutional investors at 7.16%, followed by 20.02% insiders and 72.82% retail investors. The average institutional ownership in Insight Molecular Diagnostics's industry, Diagnostics & Research Stocks, is 50.92%, which Insight Molecular Diagnostics falls below.

Who owns the most shares of Insight Molecular Diagnostics?

Insight Molecular Diagnostics’s largest shareholders are Broadwood capital (11.93M shares, 39.15%), Awm investment company (2.81M shares, 9.21%), and Pura vida investments (947.13K shares, 3.11%). Together, they hold 51.47% of Insight Molecular Diagnostics’s total shares outstanding.

Does Blackrock own Insight Molecular Diagnostics?

BlackRock is not among the top 10 institutional shareholders of Insight Molecular Diagnostics.

Who is Insight Molecular Diagnostics’s biggest shareholder by percentage of total assets invested?

Pura vida investments is Insight Molecular Diagnostics’s biggest shareholder by percentage of total assets invested, with 20.88% of its assets in 947.13K Insight Molecular Diagnostics shares, valued at 3.11M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools